Krebs von den Lungen-6 surveillance in immune checkpoint inhibitor-induced pneumonitis

Krebs von den Lungen-6 surveillance in immune checkpoint inhibitor-induced pneumonitis

Background The immune-related adverse event (irAE), pneumonitis, is a potentially fatal complication of immune checkpoint inhibitors (ICIs). Preventing its progression is crucial, emphasizing the need for effective screening tests. We evaluated the feasibility of using Krebs von den Lungen-6 (KL-6),...

Full description

Bibliographic Details
Main Authors: Isamu Okamoto, Kazuya Tsubouchi, Ryosuke Matsukane, Shoji Nakamura, Haruna Minami, Yasuto Yoneshima, Kojiro Hata, Sai Yasukochi, Kimitaka Suetsugu, Takeshi Hirota
Format: Article
Language:English
Published: BMJ Publishing Group 2024-12-01
Series:Journal for ImmunoTherapy of Cancer
Online Access:https://jitc.bmj.com/content/12/12/e010114.full

Internet

https://jitc.bmj.com/content/12/12/e010114.full

Similar Items